In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency of randomized ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...

The clinical trial was conducted at ten study centers in Spain and Russia between October 2020 ... More information: Maria ...

Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement for Novartis on the safety issue, with Beovu (brolucizumab) found to be roughly equivalent to Bayer ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Before propensity matching, mothers of tetracycline-exposed infants were more often in the youngest and oldest age strata and ...

Baricitinib significantly reduced SALT scores at 24 weeks, demonstrating superior efficacy over placebo in clinical trials.

The trials focused on women with moderate to severe vasomotor symptoms, evaluating fezolinetant's safety and efficacy.

X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) ...